Guggenheim Capital LLC Trims Stake in Ceridian HCM Holding Inc. (NYSE:CDAY)

Posted by Defense World Staff on Sep 5th, 2023

Guggenheim Capital LLC decreased its position in shares of Ceridian HCM Holding Inc. (NYSE:CDAY – Free Report) by 18.1% during the first quarter, according to its most recent filing with the SEC. The firm owned 11,282 shares of the company’s stock after selling 2,490 shares during the period. Guggenheim Capital LLC’s holdings in Ceridian HCM were worth $826,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the company. Sentry Investment Management LLC grew its holdings in shares of Ceridian HCM by 15.3% during the 4th quarter. Sentry Investment Management LLC now owns 1,019 shares of the company’s stock worth $65,000 after acquiring an additional 135 shares during the period. Texas Permanent School Fund grew its stake in shares of Ceridian HCM by 0.8% in the 4th quarter. Texas Permanent School Fund now owns 21,119 shares of the company’s stock worth $1,355,000 after buying an additional 166 shares during the last quarter. Xponance Inc. grew its stake in shares of Ceridian HCM by 0.7% in the 1st quarter. Xponance Inc. now owns 23,084 shares of the company’s stock worth $1,690,000 after buying an additional 167 shares during the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in shares of Ceridian HCM by 1.6% in the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 12,438 shares of the company’s stock worth $911,000 after buying an additional 195 shares during the last quarter. Finally, Fifth Third Bancorp grew its stake in shares of Ceridian HCM by 2.8% in the 1st quarter. Fifth Third Bancorp now owns 8,058 shares of the company’s stock worth $590,000 after buying an additional 220 shares during the last quarter.

Insider Buying and Selling

In related news, CEO Leagh Erin Turner sold 6,000 shares of the firm’s stock in a transaction on Friday, July 7th. The stock was sold at an average price of $65.34, for a total value of $392,040.00. Following the transaction, the chief executive officer now directly owns 245,201 shares of the company’s stock, valued at approximately $16,021,433.34. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, EVP William Everett Mcdonald sold 373 shares of the firm’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $71.42, for a total value of $26,639.66. Following the transaction, the executive vice president now directly owns 48,511 shares of the company’s stock, valued at approximately $3,464,655.62. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, CEO Leagh Erin Turner sold 6,000 shares of the business’s stock in a transaction dated Friday, July 7th. The shares were sold at an average price of $65.34, for a total value of $392,040.00. Following the completion of the transaction, the chief executive officer now owns 245,201 shares in the company, valued at $16,021,433.34. The disclosure for this sale can be found here. In the last three months, insiders have sold 50,873 shares of company stock valued at $3,451,754. 4.50% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several analysts recently weighed in on CDAY shares. Citigroup upped their price target on Ceridian HCM from $74.00 to $84.00 and gave the stock a “buy” rating in a research note on Friday, July 21st. Barclays upped their price target on Ceridian HCM from $73.00 to $74.00 and gave the stock an “equal weight” rating in a research note on Thursday, August 3rd. Piper Sandler upped their price target on Ceridian HCM from $70.00 to $73.00 and gave the stock a “neutral” rating in a research note on Thursday, August 3rd. Finally, TD Cowen downgraded Ceridian HCM from an “outperform” rating to a “market perform” rating and increased their target price for the company from $69.00 to $71.00 in a research note on Thursday, July 13th. Six equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to MarketBeat, Ceridian HCM presently has a consensus rating of “Moderate Buy” and a consensus price target of $79.07.

Check Out Our Latest Research Report on CDAY

Ceridian HCM Price Performance

NYSE CDAY opened at $73.11 on Tuesday. The business’s fifty day moving average price is $69.69 and its 200-day moving average price is $67.83. The stock has a market capitalization of $11.24 billion, a price-to-earnings ratio of -812.24, a PEG ratio of 4.48 and a beta of 1.42. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.10 and a quick ratio of 1.10. Ceridian HCM Holding Inc. has a 1-year low of $51.52 and a 1-year high of $79.66.

Ceridian HCM (NYSE:CDAY – Get Free Report) last released its quarterly earnings results on Wednesday, August 2nd. The company reported $0.06 earnings per share for the quarter, missing the consensus estimate of $0.07 by ($0.01). The firm had revenue of $365.90 million for the quarter, compared to the consensus estimate of $358.05 million. Ceridian HCM had a negative net margin of 0.95% and a positive return on equity of 0.67%. On average, equities analysts predict that Ceridian HCM Holding Inc. will post 0.39 earnings per share for the current year.

Ceridian HCM Profile

(Free Report)

Ceridian HCM Holding Inc, together with its subsidiaries, operates as a human capital management (HCM) software company in the United States, Canada, and internationally. It offers Dayforce, a cloud HCM platform that provides human resources, payroll, benefits, workforce management, and talent management functionality; and Powerpay, a cloud HR and payroll solution for the small business market.